Clinical Trial Update: Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Primary CNS Lymphoma [NA]

View source ↗

Summary

A completed clinical trial evaluating the combination of chemotherapy and rituximab in newly diagnosed primary central nervous system lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: University of California, San Francisco | Conditions: Brain and Central Nervous System Tumors, Lymphoma | NA | Status: COMPLETED